A 35-year-old pregnant woman visited our outpatient clinical questioning the safety of once daily 50 mg mercaptopurine (MP) during pregnancy and lactation, which was successfully treating her Crohn's disease. We measured MP and its metabolites in plasma and breast milk and found after 4 hours of intake of MP, no MP or its metabolites in breast milk. We concluded that 4 hours after intake of MP, no exposure of the suckling infant to MP and its metabolites was found while being breastfed.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1089/bfm.2019.0101 | DOI Listing |
Publication Analysis
Top Keywords
breast milk
12
metabolites breast
8
hours intake
8
mercaptopurine metabolites
4
milk 35-year-old
4
35-year-old pregnant
4
pregnant woman
4
woman visited
4
visited outpatient
4
outpatient clinical
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!